 |
| Microsoft launches a tool to recruit corona recruits to treat the injured |
Microsoft announced today (Monday) the launch of a self-assessment tool that allows people to review their eligibility to donate plasma to help people with the new Coronavirus (COVID-19) epidemic.
The new tool is part of a collaboration between the American software giant and a group called CoVIg-19 Plasma Alliance. Note that a person's immune system has a virus that produces antibodies to the virus. Once the affected people recover, they have these antibodies in their blood.
“As long as Covid-19 patients recover early from recovered plasma, the coalition can manufacture potential therapeutic drugs and start clinical trials,” says an article published by Microsoft. "These trials will determine this treatment. Whether the Covid-19 method can treat patients at risk of serious complications," she added.
It has been shown that delivering antibody-filled plasma from newly acquired patients to newly infected patients who have not yet had antibodies can help patients recover faster. This is not said to be a new treatment as it was used effectively to treat diphtheria in the 1890s and during the 1918 flu pandemic. Plasma injections are also used to treat SARS, measles and smallpox. People with diseases.
Regarding (Covid-19), some preliminary information indicates that plasma injections may help some patients recover, but it is too early to determine the therapeutic effects. Researchers in the United States continue to carry out controlled blood transfusion studies in patients (Covid-19).
The goals of the plasma alliance are different from other plasma initiatives: they do not want to transfer plasma directly to infected patients, but a treatment called H-Ig. This process collects multiple plasma donations. After that, the antibody concentrates in a liquid form and researchers will try to use it to produce drugs that can treat the virus. This treatment must undergo clinical studies before being approved for treating patients (Covid-19).
Microsoft's new screening tool, CoVIg-19 Plasma Bot (Microsoft hopes to make it available online, social media, and research channels) has been asked a number of questions to determine whether users can donate plasma, including questions about the drug. Flooded due to allergies and other diseases.